Examines the consequences of a recent dramatic reduction of Medicaid reimbursement funding for a program that since the late 1980s has provided evidence-based case management, maternity outreach and postpartum services to low-income women and their children, and contributed to improved birth outcomes in these at-risk populations.
The researchers will use claims data to examine adherence, utilization, and cost of anti-hypertensives, anti-diabetic medications, lipid-lowering drugs, anti-psychotics, anti-depressants, and seizure-disorder medications among individuals with chronic conditions.
The study includes three research aims to characterize the diffusion of psychotropic medication across a range of insurance settings, both managed and non-managed care, nationally and in several local markets in an effort to understand the inhibitors and promoters of the adoption and diffusion rate of new pharmaceutical technologies in the mental health area.
We will use North Carolina Medicaid claims and enrollment data from two years before the implementation of Medicare Part D to the first two years afterwards to provide timely evidence on the impact that Medicare Part D has had on dual eligible recipients with SMI.
A Randomized Clinical Trial Assessing the Cost-Effectiveness of Generalist Care Managers for the Treatment of Depression in Medicaid Recipients in Primary Care Settings
The goal is to assess the cost-effectiveness of generalist care managers vs. usual care in the treatment of depression in Medicaid patients seen in community-based primary health care practices.
The purpose of the project is to create a data infrastructure for comparative effectiveness research by linking health care data bases relevant to the care of complex patients and conducting a small research study as proof of concept that the infrastructure created is accessible and can be used to address important questions in comparative effectiveness research.